TY  - CHAP
M1  - Book, Section
TI  - Disorders of Hemostasis, Thrombosis, & Antithrombotic Therapy Year in Review
A1  - Papadakis, Maxine A.
A1  - McPhee, Stephen J.
A1  - Rabow, Michael W.
A1  - McQuaid, Kenneth R.
PY  - 2023
T2  - Current Medical Diagnosis & Treatment 2023
AB  - For  patients  with  morbid  obesity,  standard  doses  of  apixaban  or  rivaroxaban  should  be  chosen  rather  than  dabigatran  or  edoxaban.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/24
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1193123543
ER  -